Filing Details

Accession Number:
0001384101-17-000060
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-04 17:14:03
Reporting Period:
2017-10-02
Accepted Time:
2017-10-04 17:14:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1449535 M Christopher Hall 6000 Shoreline Court
Suite 300
South San Francisco CA 94080
President And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-02 20,000 $0.80 40,000 No 4 M Direct
Common Stock Disposition 2017-10-02 20,000 $9.00 20,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2017-10-02 20,000 $0.80 20,000 $0.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
80,000 2020-03-30 No 4 M Direct
Footnotes
  1. Includes an aggregate of 20,000 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
  2. The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 16, 2017.
  3. Represents actual sale price.
  4. The option became exercisable as to 25% of the shares on March 15, 2011, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.